News

Lab Thread Ltd, a UK-based life science software company, today announced the launch of a new Model Context Protocol (MCP) server that lets scientists connect their own AI assistants directly to their laboratory data. The launch coincides with Lab Thread’s formal incorporation in the United States, and opening of a Boston office, enabling US-based customers to engage with Lab Thread under a local entity, and extending support for the Company's growing base of customers in the region.

VectorBuilder, a global leader in gene delivery technologies, has announced it has been named “Overall CGT Solution Provider of the Year” in the sixth annual BioTech Breakthrough Awards, recognizing innovation across the global life sciences and biotechnology industries.

Creative Biolabs connects immunoliposome formulation, physicochemical characterization and in vitro release analysis to help R&D teams compare antibody-targeted liposome candidates.

Tom Fripp, founder and managing director of Addparts, discusses the limitations of conventional predictive and preventative maintenance, and how digital spares management, supported by controlled digital records and pre-agreed recovery routes, can help manufacturers build greater readiness and respond more effectively to equipment failure.

The Industrial Biotechnology Innovation Catalyst (IBIC) invites proposals for short, academic-led, industry-informed, collaborative proof of concept projects that demonstrate how biomanufacturing can address defined technical challenges across advanced manufacturing.

The latest Budget brings a mixed picture for R&D tax relief, with welcome steps towards simplifying the claims process, but disappointment that relief rates remain unchanged.

Creative Biolabs outlines research support for subcellular, microorganism, and disease-associated targeting strategies.

Pioneer Group – the company leading the regeneration of the Grafton Centre – has announced Cambridge-based Envision Health as the winner of its first accelerator programme, aimed at supporting the city’s early-stage tech companies.

Rapid-build cleanroom pods providing effective segregation and higher-classified environments around sensitive production equipment for a wide range of engineering and Life Science applications

If an abandoned drug asset can be rescued, what exactly is being created, and how should intellectual property strategy support it?

Search is changing. Your brand needs to change with it. For life sciences, biotech, pharma and healthcare organisations, visibility means Google search results. New players are now in the search space. You need to appear in the right searches and build recognition with the audiences that matter, so how can you show up in ALL of the places where people are looking and researching?

Codis has reached another major milestone in the expansion of its Haverhill, UK facility, completing demolition and beginning construction for its new commercial-scale PSD-4 spray drying capability. The investment will significantly expand Codis’ solvent-based spray drying capacity and, alongside its Nottingham capabilities, strengthen its ability to support pharmaceutical customers from development through to commercial manufacture.

BDTP is offering life science companies the opportunity to host talented bioscience PhD students for three-month professional placements. With students continuing to receive their BBSRC-funded stipend, it's an excellent way for businesses to gain additional skills and resource while helping develop the next generation of life science talent.

Powered by GrowAI and delivered by a partnership led by Manchester Metropolitan University, ChallengeAI connects businesses with universities, researchers and industry experts through funded pathways designed to support the responsible adoption of Artificial Intelligence (AI).

Whether you’re exploring new opportunities, tackling sector-specific challenges or developing innovative solutions, the ChallengeAI partnership is here to help your organisation unlock the potential of AI.

Are you a Liverpool City Region business developing an innovative microbiome-related product, technology or service?

The Microbiome Innovation Fund is now calling for applications from businesses looking to accelerate research, development, testing, validation or commercialisation of microbiome-focused innovations.

Human microglia products and functional assays support studies of brain immune activity, neuronal signalling and early-stage evaluation of therapeutic candidates.

DataLoch, a data service developed by the University and NHS Lothian, focuses on making health and care data research-ready. Recent improvements have seen the addition of more datasets, while there are case studies focussing on recent PhD graduates’ use of DataLoch and how the optimisation of NHS Lothian’s CT scanners have benefitted from DataLoch’s support.

To support UK businesses working at the forefront of AI innovation, Innovate UK has launched the Frontier AI: SME Champions, Phase 1 competition, making up to £3.1 million available for early-stage feasibility and industrial research projects.

Manchester Met has been allocated £16 million from the Greater Manchester Good Growth Fund to establish FUSE-M, a groundbreaking innovation facility bringing together immersive technologies, AI and advanced manufacturing to help businesses develop, test and commercialise new ideas.

The Bionow BioIgnite conference returned to Sci-Tech Daresbury, bringing together 90 life sciences leaders, innovators, researchers and growing businesses for a day of insight, discussion and new connections.

Built around the theme Sparking Growth Through Collaboration, the conference explored the ideas, capabilities and partnerships supporting life sciences innovation across the North. Attendees also had the opportunity to take part in tours of Sci-Tech Daresbury’s laboratory, technology and workspace facilities before the main programme began.

Arttia Creative deliver both your biotech brand identity and your biotech website. No need for two different agencies. Your brand is more than a logo, colour palette or collection of carefully chosen words. It’s the perception people form of your organisation, what you stand for, what makes you different and, importantly, why they should trust you.

Brand marketing and brand discoverability matter more than ever. Arttia Creative are here to support you with both.

Creative Biolabs highlights how antibody production, immune-cell modulation, and antibody-cytokine fusion strategies can expand the experimental toolkit for researchers studying tumor-directed immune responses.

Bionow start-up award winner Revela Health advance AI-powered endometriosis detection with Arrow support

Established in 1971, the global life sciences and chemical industry workforce solutions partner marks 55 years of supporting scientific innovation through specialist expertise and leadership.

Eligible businesses will be exempted from the indirect costs of the Renewables Obligation, Feed-in Tariffs and the Capacity Market, worth up to £40 per MWh, with exemptions reaching bills from April 2027.

You can browse our occupier directory and see the organisations that call Newcastle Helix home. But our Who's at Helix? series is about getting beyond the names and meeting the people behind them. Next up, we meet Jurek, founder of Nanovery.

The University of Manchester has maintained the highest possible rating for ‘IP and commercialisation’ in the latest Knowledge Exchange Framework (KEF6), recognising continued strength in translating University research and intellectual property into new technologies, spinout companies and commercial opportunities.

The RDA brought together partners from industry, academia and government to establish the Centre of Expertise in Advanced Materials and Sustainability (CEAMS) in 2023. Since then, businesses have been able to connect with a national network of specialist expertise, facilities and innovation support through the CEAMS partners, including The University of Manchester, the Henry Royce Institute, National Physical Laboratory (NPL), CPI and NCC.

Scaling a life sciences business brings many challenges. Funding, recruitment, regulation, commercialisation and developing the science itself can understandably dominate the agenda. But physical space can quickly become part of the scale-up conversation too.

Opportunity for SMEs (UK and EU) to access the facilities housed at The Edinburgh Super-Resolution Imaging Consortium (ESRIC), which is based at the Institute of Genetics and Cancer, Western General Hospital